Three strikes and you’re out? Not for Supernus and its Parkinson’s disease infusion pump. | The device is meant to allow ...

MRI-Compatible IV Infusion Pump Systems MarketThe global market for MRI-compatible IV infusion pump systems is set for significant expansion, driven by advancements in medical imaging and increasing ...

These medications come with significant limitations, especially in the later stages of the disease, which can be listed as follows: Infusion therapy for Parkinson’s disease (PD) involves the ...

Despite strong revenue growth, Baxter struggles with profitability and high long-term debt. Click here to read why BAX stock ...

Symbiq raises the bar for infusion pump technology with an innovative and user-centric approach. With its unique combination of nurse-friendly features, auto-default to safety software ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

Baxalta spinoff was successful, Baxter's financial results fell substantially in 2022-23 on external pressures, such as inflation and weak medical utilization trends. With medical utilization rising, ...

Shares of Supernus Pharmaceuticals (NASDAQ:SUPN) climbed 5.5% Tuesday as the U.S. Food and Drug Administration approved ...

The company could announce the separation of the business, which consists of biosciences and diagnostic solutions, at the ...

Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to 30% ...